JP2020521790A5 - - Google Patents

Download PDF

Info

Publication number
JP2020521790A5
JP2020521790A5 JP2019566112A JP2019566112A JP2020521790A5 JP 2020521790 A5 JP2020521790 A5 JP 2020521790A5 JP 2019566112 A JP2019566112 A JP 2019566112A JP 2019566112 A JP2019566112 A JP 2019566112A JP 2020521790 A5 JP2020521790 A5 JP 2020521790A5
Authority
JP
Japan
Prior art keywords
composition according
activator
effective amount
composition
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019566112A
Other languages
English (en)
Japanese (ja)
Other versions
JP7278969B2 (ja
JP2020521790A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2018/000693 external-priority patent/WO2018220444A2/en
Publication of JP2020521790A publication Critical patent/JP2020521790A/ja
Publication of JP2020521790A5 publication Critical patent/JP2020521790A5/ja
Priority to JP2023077694A priority Critical patent/JP7682226B2/ja
Application granted granted Critical
Publication of JP7278969B2 publication Critical patent/JP7278969B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019566112A 2017-05-30 2018-05-30 ドライアイ症候群を治療するための抗生物質マクロライドを送達する組成物および方法 Active JP7278969B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023077694A JP7682226B2 (ja) 2017-05-30 2023-05-10 ドライアイ症候群を治療するための抗生物質マクロライドを送達する組成物および方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762512682P 2017-05-30 2017-05-30
US62/512,682 2017-05-30
PCT/IB2018/000693 WO2018220444A2 (en) 2017-05-30 2018-05-30 Compositions and methods for treating dry eye syndrome delivering antibiotic macrolide

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023077694A Division JP7682226B2 (ja) 2017-05-30 2023-05-10 ドライアイ症候群を治療するための抗生物質マクロライドを送達する組成物および方法

Publications (3)

Publication Number Publication Date
JP2020521790A JP2020521790A (ja) 2020-07-27
JP2020521790A5 true JP2020521790A5 (https=) 2021-07-26
JP7278969B2 JP7278969B2 (ja) 2023-05-22

Family

ID=64456159

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019566112A Active JP7278969B2 (ja) 2017-05-30 2018-05-30 ドライアイ症候群を治療するための抗生物質マクロライドを送達する組成物および方法
JP2023077694A Active JP7682226B2 (ja) 2017-05-30 2023-05-10 ドライアイ症候群を治療するための抗生物質マクロライドを送達する組成物および方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023077694A Active JP7682226B2 (ja) 2017-05-30 2023-05-10 ドライアイ症候群を治療するための抗生物質マクロライドを送達する組成物および方法

Country Status (7)

Country Link
US (1) US20200147055A1 (https=)
EP (1) EP3630042A4 (https=)
JP (2) JP7278969B2 (https=)
KR (1) KR20200069261A (https=)
CN (1) CN111278401B (https=)
CA (1) CA3065474A1 (https=)
WO (1) WO2018220444A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022096931A2 (en) * 2020-11-09 2022-05-12 Eximore Ltd. Punctal plugs containing micelle-encapsulated ophthalmic pharmaceuticals and methods for making thereof
WO2024069230A2 (en) * 2022-09-29 2024-04-04 Eximore Ltd. Ophthalmic compositions and methods for sustained drug release

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5443505A (en) * 1993-11-15 1995-08-22 Oculex Pharmaceuticals, Inc. Biocompatible ocular implants
AU777915B2 (en) * 1999-04-30 2004-11-04 Sucampo Ag Use of macrolide compounds for the treatment of dry eye
US20030018044A1 (en) * 2000-02-18 2003-01-23 Peyman Gholam A. Treatment of ocular disease
US6489335B2 (en) * 2000-02-18 2002-12-03 Gholam A. Peyman Treatment of ocular disease
CA2539324A1 (en) * 2003-09-18 2005-03-31 Macusight, Inc. Transscleral delivery
US7087237B2 (en) * 2003-09-19 2006-08-08 Advanced Ocular Systems Limited Ocular solutions
CN101437478A (zh) * 2004-10-04 2009-05-20 Qlt美国有限公司 聚合送递制剂的眼部送递
DE602004017477D1 (de) * 2004-11-09 2008-12-11 Novagali Pharma Sa Öl-in-Wasser-Emulsion mit niedriger Konzentration des kationischen Mittels und positivem Zetapotential
JP4974903B2 (ja) * 2005-02-09 2012-07-11 参天製薬株式会社 疾患または状態を処置するための液体処方物
EP2004172B1 (en) * 2006-03-31 2019-03-13 Mati Therapeutics Inc. Drug delivery structures and compositions for nasolacrimal system
UY30883A1 (es) * 2007-01-31 2008-05-31 Alcon Res Tapones punctales y metodos de liberacion de agentes terapeuticos
EP2320972B1 (en) * 2008-05-08 2020-07-01 MiniPumps, LLC Implantable drug-delivery devices
EP2376019A1 (en) * 2008-12-19 2011-10-19 QLT, Inc. Substance delivering punctum implants and methods
AU2011235002B2 (en) * 2010-03-31 2016-08-11 Ocuject, Llc Device and method for intraocular drug delivery
CA2798084A1 (en) * 2010-05-17 2011-11-24 Aerie Pharmaceuticals, Inc. Drug delivery devices for delivery of ocular therapeutic agents
ES2727203T3 (es) * 2011-08-29 2019-10-14 Mati Therapeutics Inc Administración por liberación sostenida de agentes activos para tratar glaucoma e hipertensión ocular
EP2916827B1 (en) * 2012-11-08 2020-06-10 Clearside Biomedical Inc. Methods for the treatment of ocular disease in human subjects
MX364310B (es) * 2013-11-05 2019-04-22 Gustavo A Garcia Sanchez Método para preparar una formulación inmunosupresora.
WO2016083891A1 (en) * 2014-11-25 2016-06-02 Eyal Sheetrit Compositions and methods for delivering a bio-active agent or bio-active agents

Similar Documents

Publication Publication Date Title
JP2012505836A5 (https=)
JP2015143836A5 (https=)
JP2013541975A5 (https=)
JP2007523049A5 (https=)
JP2020521790A5 (https=)
JP2008044945A5 (https=)
JP2017101084A5 (https=)
JP2006511373A5 (https=)
JP2015504081A5 (https=)
JP2015007131A5 (https=)
JP2015516427A5 (https=)
JP2017535592A5 (https=)
JP2013544125A5 (https=)
JP2016505023A5 (https=)
RU2011152105A (ru) Составы таблеток 3-цианохинолина и их применение
JP2016530291A5 (https=)
JP2022132411A5 (https=)
JP2017518873A5 (https=)
JP2013537037A5 (https=)
JP2019210561A5 (https=)
JP2019104717A5 (https=)
JP2018515567A5 (https=)
JP2016515550A5 (https=)
EA201170784A1 (ru) Гранулы тамсулозина для фиксированной комбинации
JP2006506536A5 (https=)